Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M510354200 on October 27, 2005

J. Biol. Chem., Vol. 281, Issue 1, 383-391, January 6, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/1/383    most recent
M510354200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tomasinsig, L.
Right arrow Articles by Zanetti, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tomasinsig, L.
Right arrow Articles by Zanetti, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mechanistic and Functional Studies of the Interaction of a Proline-rich Antimicrobial Peptide with Mammalian Cells*

Linda Tomasinsig{ddagger}§, Barbara Skerlavaj{ddagger}, Niv Papo¶, Barbara Giabbai{ddagger}1, Yechiel Shai¶, and Margherita Zanetti{ddagger}§2

From the {ddagger}Department of Biomedical Sciences and Technology, University of Udine, P.le Kolbe 4, I-33100 Udine, Italy, §National Laboratory Interuniversity Consortium for Biotechnology, Area Science Park, Padriciano 99, I-34012 Trieste, Italy, and Department of Biological Chemistry, The Weizmann Institute of Science, Rehovot 76100, Israel

Mammalian antimicrobial peptides provide rapid defense against infection by inactivating pathogens and by influencing the functions of cells involved in defense responses. Although the direct antibacterial properties of these peptides have been widely characterized, their multiple effects on host cells are only beginning to surface. Here we investigated the mechanistic and functional aspects of the interaction of the proline-rich antimicrobial peptide Bac7(1-35) with mammalian cells, as compared with a truncated analog, Bac7(5-35), lacking four critical N-terminal residues (RRIR) of the Bac7(1-35) sequence. By using confocal microscopy and flow cytometry, we showed that although the truncated analog Bac7(5-35) remains on the cell surface, Bac7(1-35) is rapidly taken up into 3T3 and U937 cells through a nontoxic energy- and temperature-dependent process. Cell biology-based assays using selective endocytosis inhibitors and spectroscopic and surface plasmon resonance studies of the interaction of Bac7(1-35) with phosphatidylcholine/cholesterol model membranes collectively suggest the concurrent contribution of macropinocytosis and direct membrane translocation. Structural studies with model membranes indicated that membrane-bound Bac7(5-35) is significantly more aggregated than Bac7(1-35) due to the absence of the N-terminal cationic cluster, thus providing an explanation for hampered cellular internalization of the truncated form. Further investigations aimed to reveal functional implications of intracellular uptake of Bac7(1-35) demonstrated that it correlates with enhanced S phase entry of 3T3 cells, indicating a novel function for this proline-rich peptide.


Received for publication, September 20, 2005 , and in revised form, October 26, 2005.

* This work was supported by grants from the Italian Ministry for University and Research (P.R.I.N), the Interuniversity Consortium for Biotechnology, and Regione FVG. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Present address: Biocrystallography Unit, Dept. of Biological and Technological Research, San Raffaele Scientific Institute, I-20132 Milan, Italy.

2 To whom correspondence should be addressed: Dept. of Biomedical Sciences and Technology, University of Udine, P.le Kolbe 4, I-33100 Udine, Italy. Tel.: 39-0432-494390; Fax: 39-0432-494301; E-mail: zanetti{at}icgeb.trieste.it.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Appl. Environ. Microbiol.Home page
S. Taguchi, K. Mita, K. Ichinohe, and S. Hashimoto
Targeted Engineering of the Antibacterial Peptide Apidaecin, Based on an In Vivo Monitoring Assay System
Appl. Envir. Microbiol., March 1, 2009; 75(5): 1460 - 1464.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Tomasinsig, C. Pizzirani, B. Skerlavaj, P. Pellegatti, S. Gulinelli, A. Tossi, F. D. Virgilio, and M. Zanetti
The Human Cathelicidin LL-37 Modulates the Activities of the P2X7 Receptor in a Structure-dependent Manner
J. Biol. Chem., November 7, 2008; 283(45): 30471 - 30481.
[Abstract] [Full Text] [PDF]


Home page
Plant CellHome page
D. Dou, S. D. Kale, X. Wang, R. H.Y. Jiang, N. A. Bruce, F. D. Arredondo, X. Zhang, and B. M. Tyler
RXLR-Mediated Entry of Phytophthora sojae Effector Avr1b into Soybean Cells Does Not Require Pathogen-Encoded Machinery
PLANT CELL, July 1, 2008; 20(7): 1930 - 1947.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement